Hospitals have adopted a take-no-prisoners approach in the fight with Big Pharma over the 340B drug discount program. Can this strategy hold as Congress, oversight agencies, the courts and the Trump administration ratchet up scrutiny of the program?
The healthcare industry has largely been unable to meet consumers’ expectations, but a group of health system and physician group executives shared how they plan to change that at Modern Healthcare’s Consumerism Symposium.
Long before Amazon announced its joint healthcare venture and PillPack acquisition, the e-commerce giant has been slowly growing its portfolio of medical supplies offered through its Amazon Business platform.
Nivestym is not the first biosimilar of Neupogen, which helps chemotherapy patients recover, but it reflects the Food and Drug Administration’s emphasis on bringing more biosimilars to market.
Physician-owned practices with more non-physicians earned $100,748 more in net income, according to a new report from the Medical Group Management Association.
A federal judge has granted HHS more time to respond to a series of ideas filed by the American Hospital Association to reduce the denied Medicare claims backlog. The provider trade group had attempted to fight the extension in court.